SAFC Biosciences, a member of the Sigma-Aldrich Group, and Vivalis, have reached the successful completion of the first stage of their ongoing collaboration with the launch of their Ex-Cell EBx platform, which includes Ex-Cell EBx viral growth and production media. This media is designed exclusively to support EBx cells, a chicken embryonic derived stem cell line, for growth and production of viral vaccines for therapeutic use. Under the R&D agreement, which commenced in 2004, SAFC Biosci...